Dedicated to driving more treatments to more patients more quickly by testing approved therapies for new indications
Cures Within Reach leverages the speed, safety and cost-effectiveness of testing already approved therapies for new indications to improve patient quality and length of life, serving philanthropic and/or commercial uses – driving more treatments to more patients more quickly. Read about our ongoing trials at https://www.cureswithinreach.org/programs/current-repurposing-research-projects/.
medical research, pharmaceutical, social entrepreneur, and philanthropy
Cures Within Reach leverages the speed, safety and cost-effectiveness of testing already approved treatments for unsolved diseases: driving more treatments to more patients more quickly.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 22 Oct 2013 | | |
IBM IT services, IT Services and IT Consulting | IBM IT services, IT Services and IT Consulting | Other 11 Nov 2015 | | |
Incyte Pharmaceutical, Pharmaceutical Manufacturing | Incyte Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 17 Jun 2022 31 May 2022 | | |
Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 30 Apr 2022 | |